Cardlytics CEO Amit Gupta sells 10,351 shares October 1
The reported post-conversion RSU balances were 112,500 and 25,000; the two sales had weighted-average prices of $2.710 and $2.533 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Cardlytics, Inc. (CDLX) Chief Executive Officer Amit Gupta converted 18,750 and 12,500 restricted stock units into common shares on October 1, 2026; the reported RSU balances afterward were 112,500 and 25,000, respectively. He sold 10,351 shares that day at a weighted average of $2.710 per share, at prices ranging from $2.62 to $2.94, and sold 7,382 shares on October 2 at a weighted average of $2.533 per share, at prices ranging from $2.48 to $2.635. No Rule 10b5-1 plan is reported.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
6 txns
Insider
Gupta Amit
Role
Chief Executive Officer
Sold
17,733 shs ($47K)
Approx. gross sale proceeds
$47K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F3 | 7,382 | $2.533 | $19K |
| Exercise | Restricted Stock Units F1, F4 | 18,750 | $0.00 | $0.00 |
| Exercise | Restricted Stock Unit F1, F5 | 12,500 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 18,750 | -- | -- |
| Exercise | Common Stock F1 | 12,500 | -- | -- |
| Sale | Common Stock F2 | 10,351 | $2.71 | $28K |
Holdings After Transaction:
Restricted Stock Units — 112,500 contracts (Direct);
Restricted Stock Unit — 25,000 contracts (Direct);
Common Stock — 138,906 shares (Direct)
Footnotes (5)
- F1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
- F2. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.62 to $2.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).
- F3. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.48 to $2.635, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
- F4. The RSUs vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates.
- F5. 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.
Key Figures
Common shares sold: 10,351 shares
Weighted average sale price: $2.710 per share
Common shares sold: 7,382 shares
+5 more
8 metrics
Common shares sold
10,351 shares
October 1, 2026
Weighted average sale price
$2.710 per share
October 1, 2026 sale
Common shares sold
7,382 shares
October 2, 2026
Weighted average sale price
$2.533 per share
October 2, 2026 sale
RSUs converted
18,750 RSUs
Converted into common shares on October 1, 2026
RSUs remaining
112,500 RSUs
Following the October 1, 2026 transaction
RSUs converted
12,500 RSUs
Converted into common shares on October 1, 2026
RSUs remaining
25,000 RSUs
Following the October 1, 2026 transaction
Key Terms
restricted stock unit, contingent right, weighted average sales price, vest
4 terms
restricted stock unit financial
"Each restricted stock unit represents a contingent right"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
contingent right financial
"contingent right to receive one share"
weighted average sales price financial
"price reported is a weighted average sales price"
vest financial
"RSUs vest in equal amounts quarterly"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What vesting schedules apply to CDLX CEO Amit Gupta’s reported RSUs?
The 18,750-RSU entry is subject to vesting in equal amounts quarterly over a two-year period through April 1, 2028, provided Gupta remains employed on the vesting dates. For the 12,500-share RSU entry, 50% vested on April 1, 2026; the remaining 50% vests in equal amounts quarterly over a one-year period through April 1, 2027, subject to continued employment on those dates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
